glutathione reductase activity in oxidative stress Frontiers Glutathione Pathways

Description

[DOI] [Google Scholar] 92.Sagnella S.M., Duong H., MacMillan A., Boyer C., Whan R., McCarroll J.A., Davis T.P., Kavallaris M

As a result, there is a decrease in the gene expression of immunosuppressive markers such as Arg-1 , CD206 , and IL-10 in both human and mouse colon tumors [971, 981]

Researchers propose this mechanism could show selective toxicity toward cancer cells because: Tumor cells often lack catalase and other peroxide-neutralizing enzymes Cancer microenvironments contain elevated labile iron levels Normal cells maintain robust antioxidant defenses Clinical Trial Evidence Recent Phase II trials investigating vitamin C injections in cancer treatment have reported early signals that researchers describe as promising, though the evidence remains preliminary: Pancreatic Cancer Study: In a randomized Phase II trial of 34 patients with stage 4 metastatic pancreatic cancer led by Joseph Cullen at the University of IowaPharmacological ascorbate in combination with gemcitabine and nab-paclitaxel published in Redox Biology (2024)participants who received 75 grams (75,000 mg) of IV vitamin C three times weekly alongside standard chemotherapy reached a median overall survival of 16 months, compared with 8.3 months for chemotherapy alone